The DOI matches its Crossref record; 156 of the 160 references it cites were found in a registry or an index; none of the 220 sources its claims cite is checked for support yet.
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders
Open accessAbstract
Tic disorders, including Tourette's disorder, present with a wide range of symptom severity and associated comorbidity. This Practice Parameter reviews the evidence from research and clinical experience in the evaluation and treatment of pediatric tic disorders. Recommendations are provided for a comprehensive evaluation to include common comorbid disorders and for a hierarchical approach to multimodal interventions.
Overview
CoChat Summary
TL;DR
This AACAP Practice Parameter synthesizes evidence and clinical consensus on assessing and treating pediatric tic disorders, including Tourette’s disorder, emphasizing comprehensive evaluation for comorbidity and hierarchical multimodal care. It recommends psychoeducation, behavioral therapy (HRT/C-BIT), and medication for moderate-to-severe impairment, while not endorsing deep brain stimulation, repetitive transcranial magnetic stimulation, special diets, or dietary supplements.
Key findings
- Chronic tic disorder (CTD) prevalence is estimated at 0.5% to 3%; approximately 7% of school-age children had tics in the previous year, transient tics approximately 5%, and all tics range from 5.9% to 18% in boys and 2.9% to 11% in girls, with a male preponderance of at least 2:1. Average age of onset is 7 years, peak prevalence/severity is around 9 to 12 years, 65% have remission or marked attenuation by age 18 to 20 years, and 25% have tics into adulthood.
- Comorbidity is common: 20% to 60% of Tourette’s disorder patients meet criteria for OCD and 20% to 38% of youth with OCD report comorbid tics; ADHD co-occurs in as many as 50% of all childhood CTD cases and 60% to 80% of clinically referred TD cases, with ADHD incidence 7 to 8 times greater than in the general population even in mild CTD. Learning disabilities are approximately 23% in youth with chronic tics; 36% of 200 pediatric TD cases had academic difficulties; among 138 youth with CTD, 46% had school-related problems, with comorbid ADHD symptoms at nearly 4-fold increased risk; 4.6% of youth with TD had comorbid ASD.
- Behavioral treatment: in a randomized trial comparing habit reversal training (HRT) to attention control in 25 youth, HRT was associated with a 50% response rate, 30% reduction in tic severity, and approximately 50% reduction in tic-related impairment, with 46% classified as responders versus 25% in the control arm. In the multisite C-BIT trial of 126 youth with TD, 52.5% responded to an 8-session, 10-week HRT-based intervention versus 18.5% in the control condition; tic symptom severity reduction was 51% versus 30%, with a between-groups effect size of 0.64.
- Medication/other: alpha-2 agonists have an effect size of 0.5 for tic amelioration; a meta-analysis found medium-to-large effect (0.68) in trials enrolling subjects with tics and ADHD but only small, nonsignificant benefit (0.15) in trials excluding ADHD. Risperidone was effective in pediatric TD at doses of 1.0 to 3.5 mg/day. Ziprasidone showed a 39% decrease on the YGTSS versus 16% for placebo; atomoxetine resulted in 50% tic reduction versus 33.8% with placebo; metoclopramide resulted in 39% tic reduction versus 13% with placebo; ondansetron had 54% improved versus 21% with placebo. Levetiracetam did not demonstrate significant benefit, and there was no evidence that pramipexole has efficacy in suppressing tics. Deep brain stimulation, repetitive transcranial magnetic stimulation, special diets, and dietary supplements lack empirical support and are not recommended.
Methods
- Literature search used Medline, PubMed, PsycINFO, and Cochrane Library with terms Tourette’s Disorder, Tourette syndrome, or Tic Disorder, English language, human studies, from January 1, 1965 to March 29, 2013, yielding 3,764 Medline citations, 3,172 PsycINFO citations, and 3 Cochrane reviews. The authors selected 149 publications and 25 RCTs that enrolled pediatric subjects with an effective N of at least 20 (Table 2 reports N > 20).
- Recommendations are graded as Clinical Standard [CS], Clinical Guideline [CG], Clinical Option [OP], or Not Endorsed [NE], with empirical evidence rated as randomized controlled trial [rct], controlled trial [ct], uncontrolled trial [ut], or case series/report [cs]. The Parameter was reviewed by experts and a Consensus Group and approved by the AACAP Council on July 29, 2013.
- Main analysis is an evidence synthesis and clinical consensus process producing a hierarchical approach to multimodal assessment and treatment.
Limitations
- Stated in the paper: AACAP Practice Parameters are developed to assist psychiatric decision making and are not intended to define the sole standard of care; they are not inclusive of all proper methods nor exclusive of other methods, and ultimate judgment for a particular patient must be made by the clinician in light of all circumstances, available options, and resources.
- Evident from the text: large, multisite, randomized, placebo-controlled trials for pediatric tic disorders are few; many medication studies enrolled primarily adults; most medication treatment studies target moderate to severe tics and result in symptom reduction but not remission; there are no systematic studies comparing HRT to medication or combined therapies in youth.
- Evident from the text: some areas are understudied, including non-OCD mood/anxiety disorders, explosive/rage symptoms, and complementary/alternative therapies; co-occurrence estimates may be inflated by referral bias because youth with comorbidities may be more likely to seek treatment.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 4 Not valid · 172 Not checked · 21 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“Large, multi-site, randomized, placebocontrolled trials for the treatment of tic disorders are few in number, especially in pediatric populations (Table 2).”
§ Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders > Recommendation 5. Education regarding CTD should be provided regarding expectations for course and prognosis, and treatment planning should consider classroom-based accommodations. [CS]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Active comparator trials (clonidine and pimozide versus risperidone) found risperidone at least as effective.”
§ Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders > Antipsychotic Medications
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“There are no systematic studies to date comparing HRT to medication or combined therapies in youth.”
§ Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders > Recommendation 5. Education regarding CTD should be provided regarding expectations for course and prognosis, and treatment planning should consider classroom-based accommodations. [CS]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There are no controlled pharmacological studies in youth with tic disorders and aggressive/anger outbursts.”
§ Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders > Antipsychotic Medications
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In general, CTD have a male preponderance, with a gender ratio of at least 2:1 or higher.”
§ Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders > EPIDEMIOLOGY
What the sources say
- Not checked yetcites [11] Bloch, 2006, Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome, Arch Pediatr Adolesc Med source
- Not checked yetcites [20] Scahill, 2009, Prevalence of diagnosed Tourette syndrome in persons Aged 6–17 Years—United States, 2007, Morbid Mortal Wkly Rep source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
116 more claims
Create a free account to see all 197 claims and to verify the 218 references still open.
- It may state two separate claims as one. 49
- Probably not a substantial claim. 37
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Yet, for many youngsters, it is not the tics that are most problematic but rather the co-occurring problems many youth experience.51”
From SUICIDAL THOUGHTS AND BEHAVIORS IN CHILDREN AND ADOLESCENTS WITH CHRONIC TIC DISORDERS: Research Article: Suicidal Thoughts in Chronic Tic Disorders (2015) · cites this paper as [51]
In the citing paper
“Although many youth respond to pharmacological and behavioral interventions for CTDs (Murphy et al., 2013), remission is rare and even treatment responders continue to experience tics.”
From Living with tics: Reduced impairment and improved quality of life for youth with chronic tic disorders (2015) · cites this paper as Murphy et al., 2013
In the citing paper
“professional organizations have recommended behavior therapy as the first-line intervention for youth with PTD who have mild-to-moderate tic severity [37–39]”
From Behavior Therapy for Tic Disorders: An Evidenced-based Review and New Directions for Treatment Research (2015) · cites this paper as [37]
In the citing paper
“Although recognized as an important aspect of treatment in evidence-based practice parameters [37], there have only been two studies that have evaluated treatments to address these concerns.”
From Behavior Therapy for Tic Disorders: An Evidenced-based Review and New Directions for Treatment Research (2015) · cites this paper as [37]
In the citing paper
“professional organizations recommend behavior therapy as a first-line intervention for individuals with mild-to-moderate tic severity [37]”
From Behavior Therapy for Tic Disorders: An Evidenced-based Review and New Directions for Treatment Research (2015) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders > PARAMETER LIMITATIONS
“TABLE 2 Controlled Trials in Pediatric Tourette's Disorder (TD) with N > 20”
§ Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders > Recommendation 3. The assessment for tic disorders should involve a careful examination for general medical condition or substance etiologies. [CS]
“115 12 8e27 (14.9)Crossover YGTSS Clonidine”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
The yale global tic severity scale: initial testing of a clinician-rated scale of tic severity
LECKMAN, J. F., RIDDLE, M. A., HARDIN, M. T., ORT, S. I., SWARTZ, K. L., STEVENSON, J., & COHEN, D. J. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198907000-00015 · Cited by 2,146
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
Swedo, S. E., Leonard, H. L., Garvey, M., Mittleman, B., Allen, A. J., Perlmutter, S., Dow, S., Zamkoff, J., Dubbert, B. K., & Lougee, L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.2.264 · Cited by 1,534
Achenbach, T. M., & Ruffle, T. M. (2000) · Pediatrics in Review · doi:10.1542/pir.21-8-265 · Cited by 1,285
Costello, E. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830120067012 · Cited by 1,083
Freeman, R. D., Fast, D. K., Burd, L., Kerbeshian, J., Robertson, M. M., & Sandor, P. (2000) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162200000839 · Cited by 924
Behavior Therapy for Children With Tourette Disorder: A Randomized Controlled Trial
Piacentini, J., Woods, D. W., Scahill, L., Wilhelm, S., Peterson, A. L., Chang, S., Ginsburg, G. S., Deckersbach, T., Dziura, J., Levi-Pearl, S., et al. (2010) · JAMA · doi:10.1001/jama.2010.607 · Cited by 790
Course of Tic Severity in Tourette Syndrome: The First Two Decades
Leckman, J. F., Zhang, H., Vitale, A., Lahnin, F., Lynch, K., Bondi, C., Kim, Y.-S., & Peterson, B. S. (1998) · Pediatrics · doi:10.1542/peds.102.1.14 · Cited by 685
Bloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V, Bracken, M. B., & Leckman, J. F. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001823 · Cited by 635
Research works printed but not linked: 1
- 1998, Practice parameters for the assessment and treatment of children and adolescents with language and learning disorders. AACAP, J Am Acad Child Adolesc Psychiatry, 37, 46S
Cited by
Items 201–276 of 276
Drug and Non-drug Treatment of Tourette Syndrome
Zelnik, N. (2019) · Current Drug Therapy · doi:10.2174/1574885514666191121141923
Martel, S. (2020) · Papyrus : Institutional Repository (Université de Montréal)
Pharmacotherapy profiles of children with tic disorders: A cross-sectional retrospective study (tur)
Dinç, G. Ş., Sekmen, E., Göker, Z., Çöp, E., & Üneri, Ö. Ş. (2020) · Journal of Clinical Psychiatry · doi:10.5505/kpd.2020.69672
Cultural Differences in Reactions to Tics
Stiede, J. T. (2020) · e-Publications@Marquette (Marquette University)
The Neural Substrates of Tics vs. Obsessive-compulsive Behaviours in Tourette Syndrome
Bhikram, T. (2020) · TSpace (University of Toronto)
Abi‐Jaoude, E. (2020) · TSpace (University of Toronto)
Guidelines Based on Systematic Literature Review and Meta-analysis
Cavanna, A. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108186599.008
Second-Generation Anti-dopaminergic Medications
Cavanna, A. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108186599.005
First-Generation Anti-dopaminergic Medications
Cavanna, A. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108186599.004
Montalbano, G. E., Yang, J. W., Nurmi, E. L., & Ricketts, E. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818697-8.00042-x
Repetitive throat clearing, blinking, and grimacing
Sipsock, D. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780197577479.003.0005
Arypiprazol w leczeniu tików ― analiza przeglądów systematycznych i metaanaliz
Głowacki, P., & Kowman, M. (2021) · Psychiatria · doi:10.5603/psych.2021.0028
Das, B., Rawat, V. S., Ramasubbu, S. K., Agnihotri, A., & Kumar, B. (2021) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2021.101456
Tourette syndrome: Current nosology and guidelines
Cavanna, A. E. (2022) · International review of movement disorders · doi:10.1016/bs.irmvd.2022.01.002
Fasching, L., Brady, M. V., Bloch, M. H., Lombroso, P. J., & Vaccarino, F. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813866-3.00040-0
Other Tic-Suppressing Medications
Cavanna, A. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108186599.007
Cavanna, A. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108186599.003
Alpha-2 Adrenergic Medications
Cavanna, A. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108186599.006
Guidelines Based on Expert Survey and Consensus
Cavanna, A. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108186599.009
(2020) · Cambridge University Press eBooks · doi:10.1017/9781108186599.010
Alexander, J., & Woods, D. W. (2018) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190634841.013.28
Yale Global Tic Severity Scale (YGTSS)☆
Murphy, T. K., Storch, E. A., Wolfe, A. M., & Bodzin, D. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.00863-4
Self-citationHimle, M. B., & Wellen, B. C. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316798096.008
Cavanna, A. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108186599.011
Zhang, J., Yang, C., Peng, Y., & Ni, X. (2022) · Neurology Asia · doi:10.54029/2022sju
Emotional and Behavioral Symptoms
Byrne, R., Elsner, G., & Beattie, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-76174-1.00031-6
Амонов, Ш. Э., & Эгамбердиева, З. Д. (2023) · Оториноларингология Восточная Европа · doi:10.34883/pi.2023.13.1.021
Recent advances in understanding tourette syndrome, tic disorders and functional tics
(2023) · Frontiers research topics · doi:10.3389/978-2-8325-2164-9
Awasthi, J., Harris‐Starling, C., Kalvin, C. B., Pittman, B. P., Park, H., Bloch, M. H., Fernandez, T. V., Sukhodolsky, D. G., & Hampson, M. (2023) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2023.111692
Neurodevelopmental Disorders: Stereotypical Movement Disorders and Tic Disorders
Vitulano, L. A., Vitulano, M. L., King, R. A., Yazgan, M. Y., & Leckman, J. F. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_45-1
Childhood and Adolescent Disorders
Grills, A. E., & Holt, M. K. (2015) · Wiley eBooks · doi:10.1002/9781394259229.ch9
Advances in Research on Psychotherapy for Multiple Tic Disorders
艾, 晨. (2024) · Advances in Psychology · doi:10.12677/ap.2024.141008
Đặc điểm lâm sàng rối loạn tic ở trẻ vị thành niên tại Bệnh viện Nhi Trung ương
Vinh, N. A., Long, Đ. T., & Chung, N. V. (2024) · Tạp chí Y học Dự phòng · doi:10.51403/0868-2836/2024/1708
From Zero to Overwhelm: PANS and PANDAS as Culprits Behind Sudden OCD in Pediatrics
Alnaher, S. (2024) · Journal of Medicine Nursing & Public Health · doi:10.53819/81018102t4278
Psychopharmacology for Pediatric Tics and Tourette’s Disorder
Coffey, B. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-57472-6_9
Tricamo, M., Mathews, T. L., & Walkup, J. T. (2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378524.lg08
Dimitrov, L. V., & Lewin, A. B. (2025) · Child Psychiatry & Human Development · doi:10.1007/s10578-025-01817-3
Self-citationPrescribing in Children and Adolescents
(2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg005.pub2
Kim, Y., & Aravamuthan, B. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00005-6
Woods, D. W., Piacentini, J. C., Peterson, A. L., Scahill, L. D., & Walkup, J. T. (2025) · doi:10.1093/med-psych/9780199363346.001.0001
Woods, D. W., Piacentini, J. C., Peterson, A. L., Scahill, L. D., & Walkup, J. T. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.002.0005
(2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.002.0007
Woods, D. W., Piacentini, J. C., Peterson, A. L., Scahill, L. D., & Walkup, J. T. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.002.0004
Introductory Information for Therapists
Woods, D. W., Piacentini, J. C., Peterson, A. L., Scahill, L. D., & Walkup, J. T. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0001
Behavioral Model of Tic Disorders and Mechanisms of Change
Woods, D. W., Piacentini, J. C., Peterson, A. L., Scahill, L. D., & Walkup, J. T. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0003
Woods, D. W., Piacentini, J. C., Peterson, A. L., Scahill, L. D., & Walkup, J. T. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0002
Woods, D. W., Piacentini, J. C., Peterson, A. L., Scahill, L. D., & Walkup, J. T. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.005.0001
Woods, D. W., Piacentini, J. C., Peterson, A. L., Scahill, L. D., & Walkup, J. T. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0006
Comorbidity Management: It’s Not Just Tics
Lewin, A. B. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0017
Self-citationBootes, K. R., Blount, T. H., Kudryk, K., & Himle, M. B. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0015
Occupational Therapy, Tourette Disorder, and CBIT
Rowe, J., & Martin, H. S. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0013
Assessment of Tourette Disorder
Woods, D. W., Piacentini, J. C., Peterson, A. L., Scahill, L. D., & Walkup, J. T. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0004
Woods, D. W., Piacentini, J. C., Peterson, A. L., Scahill, L. D., & Walkup, J. T. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0007
Functional Assessment and Function-Based Intervention
Woods, D. W., Piacentini, J. C., Peterson, A. L., Scahill, L. D., & Walkup, J. T. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0005
Woods, D. W., Piacentini, J. C., Peterson, A. L., Scahill, L. D., & Walkup, J. T. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0010
Sessions 7 and 8 and Booster Sessions
Woods, D. W., Piacentini, J. C., Peterson, A. L., Scahill, L. D., & Walkup, J. T. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0011
Mcguire, J. F. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0014
Woods, D. W., Piacentini, J. C., Peterson, A. L., Scahill, L. D., & Walkup, J. T. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0009
Woods, D. W., Piacentini, J. C., Peterson, A. L., Scahill, L. D., & Walkup, J. T. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0008
Woods, D. W., Piacentini, J. C., Peterson, A. L., Scahill, L. D., & Walkup, J. T. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.002.0009
Adapting CBIT for Younger Children
Bennett, S. M., & Capriotti, M. R. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0012
Ricketts, E. J., Dougherty, A. C. T., Gonzalez, A., & Chang, S. W. (2025) · Oxford University Press eBooks · doi:10.1093/med-psych/9780199363346.003.0016
Valbenazine for the Treatment of Chronic Motor or Vocal Tic Disorder (CMVTD)
Bied, A. M., Sakthivel, A. A., & Satodiya, R. M. (2025) · Cureus · doi:10.7759/cureus.92968
Chapter 3. Neurodevelopmental Disorders
(2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371457.lg03
Álvarez de Toledo Blandón, M. D. L. P. (2022) · Deposito de Investigacion Universidad de Sevilla (University of Seville)
Health and wellbeing of under-15 year olds in Hutt Valley, Capital & Coast and Wairarapa 2018
Duncanson, M., Oben, G., Adams, J., Richardson, G., Wicken, A., & Pierson, M. (2019) · Otago University Research Archive (University of Otago)
Investigating medical cannabis for adolescents with Tourette syndrome: tread carefully
Abi‐Jaoude, E. (2026) · BJPsych Open · doi:10.1192/bjo.2025.10959
Мирзоян, А. Р., Николаевна, Ч. Т., & Миронова, О. А. (2025) · Неврология и нейрохирургия Восточная Европа · doi:10.34883/pi.2025.15.4.049
Characteristics of cognitive disengagement syndrome in children diagnosed with tic disorder
Tanıgör, E. K., Özyurt, G., Karaca, B. Ş., Arısoy, D. A., & Akay, A. P. (2026) · Child Neuropsychology · doi:10.1080/09297049.2026.2628721
Li, L., Fang, X., Huimin, Z., Wang, J., Wu, H., Qian, L., & Song, H. (2026) · iScience · doi:10.1016/j.isci.2026.116672
Manejo Farmacológico e Terapia Comportamental na Síndrome de Tourette na Infância
Lacerda, J. D. S., & Ferreira, R. S. (2026) · Nursing Edição Brasileira · doi:10.36489/nursing.2026v32i340p19502-19506
Whalen, P. L., Leeb, R. T., Hutchins, H. J., Staley, B. S., Claussen, A. H., Newsome, K., Robinson, L. R., & Bitsko, R. H. (2026) · Journal of Child and Adolescent Psychopharmacology · doi:10.1177/10445463261484867
โรคซนสมาธิสั้นในเด็กและวัยรุ่น
มาศเกษม, ก. (2020) · Journal of Charoenkrung Pracharak Hospital
Eapen, V., Singer, H. S., Mathews, C. A., Martino, D., Vermilion, J. A., Cavanna, A. E., & Paschou, P. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-026-00742-6
Akaltun, İ., Kara, T., Yılmaz, C., TURAN, E., & Sayar, E. (2026) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.70627
Shou, S., Li, Y., Fan, G., Zhang, Q., Yan, Y., Lv, T., & Wang, J. (2022) · doi:10.3389/fpsyg.2022.851250.s001
Metadata
- Authors
- Murphy, T. K., Lewin, A. B., Storch, E. A., & Stock, S.
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 52
- Issue
- 12
- Pages
- 1341-1359
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W2960535177
- Semantic Scholar
- bc1943b6e0ff21b59ab7bfa16642ca3643cab9a5
- Cited by
- 276
- References
- 160
- Citations by year
- 2026: 9 · 2025: 32 · 2024: 17 · 2023: 12 · 2022: 22 · 2021: 29 · 2020: 34 · 2019: 23 · 2018: 23 · 2017: 27 · 2016: 18 · 2015: 20 · 2014: 8 · 2013: 1
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- American Academy of Child and Adolescent Psychiatry
- International OCD Foundation
- University of South Florida
- Otsuka America Pharmaceutical
- National Alliance for Research on Schizophrenia and Depression
- Otsuka America
- Shire
- National Institutes of Health (UL1TR000077)
- Centers for Disease Control and Prevention
- National Institute of Mental Health
- National Center for Advancing Translational Sciences
- Janssen Pharmaceuticals
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Clinical Psychology › Stuttering Research and Treatment
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Keywords
- tic disorders, Tourette syndrome, comorbidities, multimodal therapy, treatment guidelines, clinical evaluation, children and adolescents
- MeSH terms
- Adolescent, Child, Humans, Tic Disorders, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.